INCardio

Innovative therapies for cardiovascular disease.

INCardio
  • Project duration: October 2020 - October 2022
  • Project status:
    Ongoing
  • Funding:
    Italy-Austria 2014-2020 (EUTC / EU funding / Project)
  • Total project budget: €364,377.00
  • Website: https://www.incardio.eu/

Cardiovascular diseases affect about 30% of the European population and account approximately for 40% of deaths in Italy and 45% in Austria, according to 2015 Eurostat data.

Through a project targeted at research partners, researchers, students, medical doctors and health professionals, the ICGEB Cardiovascular Biology laboratory in Trieste, the Eurac Research -Institute for Biomedicine, Biology of Cardiac Health and Disease Group, Bolzano, the University Department of Visceral, Transplant and Thoracic Surgery, Innsbruck, and CUAS Engineering and IT in Klagenfurt, Austria, with Associated Partners, Hospital of Bolzano, Cardiology, University of Trieste, Medical Sciences, Surgery and Health, and the Merano Hospital, Cardiology, come together to create a virtual centre for excellence to target cardiovascular disease.

Collectively, the project combines multidisciplinary expertise in the fields of physiology, biology, heart transplant surgery, biomedical engineering and bioinformatics. In particular, the role of mechanical forces in controlling the heart cell characteristics will be studied. Further, cardiomyocytes derived from induced pluripotent stem cells (iPSCs) will be used to reintroduce the human context in the early stages of drug research and to explore the activity of compounds capable of modulating cardiac contractility and electrical activity.

The ICGEB Cardiovascular Biology lab has established skills in research and innovation capacities in the field to drive the development of innovative technologies and therapeutic concepts pivotal for this project. The Medical University of Innsbruck (MUI) will be developing training and knowledge exchange methodologies in the fields of ischemia-reperfusion and organ transplantation. Eurac Research will be driving the pilot actions including the search for novel cardioprotective factors and molecules controlling cardiac rhythm, and CUAS, will be responsible for the creation of a competence centre and a virtual platform for data exchange. The partnership represents pluriennial experience in Interreg projects.

Partner
University of Applied Sciences Carinthia
Medical University Innsbruck
International Centre for Genetic Engineering and Biotechnology

The project has received funding for over 1.1 million Euro and will run for two years. INCardio is Funded by the ERDF / Interreg V-A Italy-Austria 2014-2020

Scientific Output

Project Team
1 - 5

Projects

1 - 4
Project

EPIC

Epigenetics of Immunity in Cancer

Duration: September 2019 - August 2021Funding:
Italy-Austria 2014-2020 (EUTC / EU funding / Project)

view all

Institute's Projects

Institute
Eurac Research logo

Eurac Research is a private research center based in Bolzano (South Tyrol) with researchers from a wide variety of scientific fields who come from all over the globe. Together, through scientific knowledge and research, they share the goal of shaping the future.

What we do

Our research addresses the greatest challenges facing us in the future: people need health, energy, well-functioning political and social systems and an intact environment. These are complex questions, and we are seeking the answers in the interaction between many different disciplines. In so doing, our research work embraces three major themes: regions fit for living in, diversity as a life-enhancing feature, a healthy society.

ISO 9001 / 2015
ISO 9001:2015
05771/0
ISO 27001
ISO 27001:2013
00026/0
Great Place To Work

In order to give you a better service this site uses cookies. Additionally third party cookies are used. By continuing to browse the site you are agreeing to our use of cookies.

Privacy Policy